Influence Of Coffee Consumption Research Articles

The influence of coffee consumption on bioelectrical impedance parameters: a randomized, double-blind, cross-over trial.

Bioelectrical impedance analysis (BIA) is a widely used method for estimating body composition. Avoiding foods/beverages containing caffeine is a frequently enforced pre-test protocol to ensure reliability of BIA measurements. However, few studies have evaluated whether this is necessary, with conflicting results. We aimed to determine whether the coffee consumption differing in caffeine content influences BIA parameters in healthy adults. Twenty-five healthy adults were enrolled in a randomized, double-blind cross-over trial. Three amounts of caffeine were given with 200 mL of coffee: 0 mg (11 g of decaffeinated), 200 mg (5.5 g of caffeinated plus 5.5 g of decaffeinated), and 400 mg of caffeine (11 g of caffeinated). BIA measurements were conducted at 6 different times, and coefficient variations (CV) explored. No differences were observed for group × time interaction on impedance, resistance, or reactance (p > 0.05). Values of BIA parameters increased after 30-min of coffee consumption, independently of the caffeine dosage (all p < 0.001). Body fat percentage followed the same pattern and increased after 45-min (p < 0.05). Median CV for consecutive impedance, resistance, and reactance measurements were >95%CI of expected device measurement error over 70-min, without difference between groups. Urine output volume was not different between groups (decaffeinated: 440.45 ± 197.57 mL; 200 mg: 471.80 ± 171.88 mL; 400 mg: 489.30 ± 204.10 mL, p > 0.05). Coffee consumption influenced BIA-derived results after 70-min but was not related to caffeine content, likely due to water intake.

Coffee Consumption and Risk of Dementia and Alzheimer's Disease: A Dose-Response Meta-Analysis of Prospective Studies.

Coffee consumption is associated with a reduced risk of several diseases but uncertainty remains about the influence of coffee consumption on the risk of dementia. We performed a dose-response meta-analysis to summarize the prospective data on coffee consumption and associated risk of dementia and Alzheimer’s disease. We identified studies by searching PubMed (from January 1966) and Web of Science (from January 1945) through 4 October 2018 and by scrutinizing the reference lists of pertinent publications. Two researchers independently reviewed the literature. Results were combined using a restricted cubic spline random-effects dose-response meta-analysis based on a one-stage approach. Eight relevant prospective studies were identified. These studies included 7486 dementia cases diagnosed among 328,885 individuals during an average follow-up of 4.9–25 years. Meta-analysis of all eight studies indicated no statistically significant association between coffee consumption and the risk of dementia and no deviations from a linear trend (p = 0.08). The relative risk of dementia per 1 cup/day increment of coffee consumption was 1.01 (95% confidence interval (CI) 0.98–1.05; p = 0.37). Meta-analysis of five studies that focused on Alzheimer’s disease revealed no association between coffee consumption and Alzheimer’s disease and no deviations from a linear trend (p = 0.79). The relative risk of Alzheimer’s disease per 1 cup/day increment of coffee consumption was 1.01 (95% confidence interval 0.95–1.07; p = 0.80). These results do not support an association between coffee consumption and an increased risk of overall dementia or Alzheimer’s disease specifically, but further research on the association of coffee consumption with dementia risk is needed.

The Influence of Coffee Consumption for Smoking Behavior

The Influence of Coffee Consumption for Smoking Behavior

Coffee consumption and coronary heart disease risk using the Framingham risk score.

Although concerns regarding the influence of coffee consumption on human health have accompanied the massive increase in coffee consumption, the effects of coffee intake on the risk for coronary heart disease (CHD) remain controversial. Therefore, we evaluated the association between coffee consumption and CHD risk as estimated using the Framingham risk model in Korean adults. This cross-sectional study involved 3,987 participants aged 30-74 years who participated in the fifth Korea National Health and Nutrition Examination Survey conducted in 2010. The frequency of coffee consumption was self-reported and classified into 4 categories (non-drinker, 1, 2, and >=3 cups/day). The 10-year risk for CHD was determined from the Framingham risk score. Across the levels of coffee consumption, there were significant differences in the frequency of smoking among men and advanced age, low high-density lipoprotein cholesterol level, diabetes, and smoking among women. In the multiple logistic regression analyses, the adjusted odds ratios (95% CI) for >=20% 10-year CHD risk was 0.211 (0.060-0.745) for women who consumed >=3 cups of coffee per day compared with women who consumed <1 cup per day. For women, a significant dose-response inverse association between the level of coffee consumption and 10-year CHD risk persisted even after adjusting for multiple confounding factors. For the men, however, there was no significant association between coffee consumption and 10-year CHD risk. Coffee consumption is associated with a lower risk for CHD in Korean women.

Caffeine and Caffeic Acid Inhibit Growth and Modify Estrogen Receptor and Insulin-like Growth Factor I Receptor Levels in Human Breast Cancer.

Epidemiologic studies indicate that dietary factors, such as coffee, may influence breast cancer and modulate hormone receptor status. The purpose of this translational study was to investigate how coffee may affect breast cancer growth in relation to estrogen receptor-α (ER) status. The influence of coffee consumption on patient and tumor characteristics and disease-free survival was assessed in a population-based cohort of 1,090 patients with invasive primary breast cancer in Sweden. Cellular and molecular effects by the coffee constituents caffeine and caffeic acid were evaluated in ER(+) (MCF-7) and ER(-) (MDA-MB-231) breast cancer cells. Moderate (2-4 cups/day) to high (≥5 cups/day) coffee intake was associated with smaller invasive primary tumors (Ptrend = 0.013) and lower proportion of ER(+) tumors (Ptrend = 0.018), compared with patients with low consumption (≤1 cup/day). Moderate to high consumption was associated with lower risk for breast cancer events in tamoxifen-treated patients with ER(+) tumors (adjusted HR, 0.51; 95% confidence interval, 0.26-0.97). Caffeine and caffeic acid suppressed the growth of ER(+) (P ≤ 0.01) and ER(-) (P ≤ 0.03) cells. Caffeine significantly reduced ER and cyclin D1 abundance in ER(+) cells. Caffeine also reduced the insulin-like growth factor-I receptor (IGFIR) and pAkt levels in both ER(+) and ER(-) cells. Together, these effects resulted in impaired cell-cycle progression and enhanced cell death. The clinical and experimental findings demonstrate various anticancer properties of caffeine and caffeic acid against both ER(+) and ER(-) breast cancer that may sensitize tumor cells to tamoxifen and reduce breast cancer growth.

Abstract 4685: Caffeine and caffeic acid inhibit growth and modify estrogen receptor (ER)-α and insulin-like growth factor I receptor (IGF-IR) levels in human breast cancer

Abstract Estrogen receptor (ER)-α is critically involved in breast cancer development, progression and disease management. Emerging evidence indicate that epigenetic and non-epigenetic mechanisms may be a frequent cause for loss of ERα during tumor progression, which in turn may be modifiable by dietary and lifestyle factors. In line with epidemiological reports on chemopreventive effects by coffee on breast cancer risk and prognosis, we assessed the influence of coffee consumption on tumor characteristics in an extended cohort of 1090 patients with invasive primary breast cancer in southern Sweden, aged 24-99 years, with preoperatively reported daily coffee consumption. Moderate (2-4 cups/day) to high (5+ cups/day) daily coffee intake were associated with significantly smaller invasive primary tumor sizes (Ptrend = 0.013), while concomitantly lower frequency of ER+ tumors (Ptrend = 0.018), compared to women with low coffee consumption (≤1 cup/day). To establish how coffee intake may alter molecular mechanisms with impact on breast cancer growth in relation to ER status, we extended our clinical observations to in vitro models of ER+ (MCF-7) and ER- (MDA-MB-231) human breast cancer cells. Exposure to the coffee constituents caffeine and caffeic acid significantly suppressed the proliferation of both ER+ (by 59% and 38%, respectively) and ER- (by 47% and 28%, respectively) human breast cancer cells. In line with the clinical observations, the ER+ breast cancer cells appeared more sensitive to the growth inhibitory effects by the coffee constituents compared to ER- cells. The antiproliferative actions were associated with altered ER levels. We found that caffeine destabilized ERα and reduced ERα abundance in ER+ cells, while caffeine and caffeic acid enabled re-expression of ERα in ER- cells, both resulting in growth inhibition. In addition, caffeine reduced the levels of the mitogenic insulin-like growth factor type I receptor (IGF-IR) in both ER+ and ER- breast cancer cells. Together the effects by caffeine and caffeic acid on ER and IGF-IR abundance with impact on downstream effectors, resulted in impaired G1 to S transition with incapacity to complete the cell cycle and enhanced cell death. In summary, this study demonstrate multiple anticancer properties of caffeine and caffeic acid against both ERα-positive and ERα-negative breast cancer in vitro that may sensitize tumor cells to current endocrine therapies. Together these experimental and clinical findings provide a more comprehensive understanding of the functional and mechanistic effects of these dietary factors that can modify cancer progression. Citation Format: Ann H. Rosendahl, Claire M. Perks, Andrea Markkula, Maria Simonsson, Carsten C. Rose, Christian Ingvar, Jeff MP Holly, Helena Jernström. Caffeine and caffeic acid inhibit growth and modify estrogen receptor (ER)-α and insulin-like growth factor I receptor (IGF-IR) levels in human breast cancer. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 4685. doi:10.1158/1538-7445.AM2014-4685

Excretion of volatile nitrosamines in a rural population in relation to food and drinking water consumption

Urinary excretion of volatile nitrosamines was assessed in 59 non-smokers living in a rural county of Québec, Canada. Water and food intakes were measured by means of a 24-hour recall. Nitrates were analyzed in the tap water of all participants (geometric mean=2.0 mg nitrate-N/L) and dietary intakes of nitrate and vitamins C and E were estimated via a validated Canadian food database. Urine was collected over the same 24-hour period and analyzed for nitrates by hydrazine reduction and for volatile nitrosamines by gas-chromatography/mass spectrometry. N-Nitrosopiperidine (NPIP) was found in urine samples from 52 of the 59 subjects. Geometric mean of NPIP urinary excretion was 67 ng/day and maximum value was 1045 ng/day. No other volatile nitrosamine was detected. There was a correlation between urinary nitrate excretion and total nitrate intake (r=0.71, P < 0.001). However, no relationship was found between urinary NPIP excretion and either nitrate excretion, dietary or water nitrate intakes. NPIP excretion was significantly correlated to coffee intake (r=0.40, P=0.002) and this relation was not modified by vitamin intake. We conclude that nitrate intake is not related to nitrosamine excretion in this rural population. The influence of coffee consumption on NPIP excretion deserves further attention.

Effects of coffee consumption on iron, zinc and copper status in nonpregnant and pregnant Sprague-Dawley rats

To investigate the influence of coffee consumption on iron, zinc and copper status, 64 Sprague-Dawley female rats were assigned to four treatment groups: nonpregnant-given coffee, nonpregnant-given water, pregnant-given coffee and pregnant-given water. The coffee groups received a freeze-dried coffee solution (1.1% w/v) as the sole source of liquids during the 18-day study period; all groups were provided a purified diet marginal in iron ad libitum. On day 18 (of gestation in the pregnant rats), rats were intubated with 0.033 MBq 59Fe after an 8 h fast and killed 4, 8, 12 or 24 h post-gavage. Fluid intake was significantly lower in the coffee groups. Coffee did not affect food consumption, weight gain, hemoglobin or hematocrit in either pregnant or nonpregnant rats. In nonpregnant rats, the percentage of 59Fe was lower in plasma and higher in the spleen and erythrocytes in the coffee group than in controls; in pregnant rats the coffee group had a higher percentage of 59Fe in the stomach (at 4 h only), blood, spleen and bone than controls. There were no significant effects of coffee on tissue concentrations of Fe, Zn or Cu in the nonpregnant group, but pregnant rats given coffee had high concentrations of Fe in the liver, bone and placenta, and low placenta Zn concentrations compared to controls. In fetuses, there were trends towards lower weight, length, and percentage 59Fe, but higher liver Fe, in the coffee group than in the controls. The results suggest that coffee intake leads to (a) increased attempts at erythropoeisis, an indication of iron deficiency, in both nonpregnant and pregnant rats, and (b) impaired placental Fe transport.

Coffee consumption as a factor in iron deficiency anemia among pregnant women and their infants in Costa Rica

The influence of coffee consumption on hematological and trace element status was studied in two groups of pregnant, low-income Costa Rican women: coffee drinkers (greater than or equal to 450 mL/d, n = 22) and coffee nondrinkers (0 mL/d, n = 26). Groups had similar income, education, prenatal care, age, parity, weight, height, pregnancy weight gain, prenatal iron supplementation, energy, protein, Fe, and vitamin C intake and infant sex and gestational age. Maternal hemoglobin (Hb) and hematocrit (Hct) at 8 mo gestation, cord blood Hb and Hct, infant birth weight and Hb and Hct at 1 mo of age, and breast-milk Fe concentration were significantly lower in the coffee group than in the noncoffee group. The association of coffee with infant Hb and Hct was independent of maternal Fe status and birth weight. These results are consistent with our previously reported data in rats and indicate that maternal coffee intake may contribute to maternal and infant anemia.